Results 191 to 200 of about 111,791 (264)

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

Epilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang, Emilio Perucca, Samuel F. Berkovic, Piero Perucca   +3 more
wiley   +1 more source

Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot study. [PDF]

PLoS One
Lawrence MR, Arnetz JE, Counts SE, Ahmed A, Arnetz BB.   +4 more
europepmc   +1 more source

Sex-, age-, and education-adjusted norms for Cambridge Neuropsychological Test Automated Battery in literate Sri Lankan adults

, 2019
Tharaka L. Dassanayake, Dewasmika Indrapali Ariyasinghe   +1 more
openalex   +1 more source

Self‐completed patient‐reported outcome measures in adults with epilepsy: A review

Epilepsia Open, EarlyView.
Abstract Epilepsy affects 65 million people worldwide, and is a World Health Organization priority disease as highlighted in their 2022–2031 Intersectoral Global Action Plan (IGAP) on Epilepsy and other Neurological Disorders. IGAP's objectives include improving epilepsy treatment and care.
Alison L. Conquest, Terence J. O'Brien, Patrick Kwan, Jacqueline A. French, Charles B. Malpas, Emma C. Foster   +5 more
wiley   +1 more source

Among common neuropsychological tests, the Paced auditory serial addition test is the strongest predictor of trait fatigue in patients with traumatic brain injury. [PDF]

J Neuropsychol
Berginström N, Thelander J, Nordström P, Nordström A.   +3 more
europepmc   +1 more source

Late‐onset unexplained epilepsy as a risk factor for cognitive impairment and dementia: Protocol for a multi‐center prospective longitudinal observational study (ELUCID)

Epilepsia Open, EarlyView.
Abstract Objective Late‐onset unexplained epilepsy (LoUE), defined as epilepsy onset after age 55 without an obvious cause, is an important risk factor for dementia. Studies have shown that 10%–25% of individuals with LoUE develop dementia within 3–4 years following their first seizure.
Alice D. Lam, Emily L. Johnson, Rani A. Sarkis, Leah J. Blank, Tyler E. Gaston, Mouhsin M. Shafi, Rodrigo Zepeda, Kyle R. Pellerin, Nathalie Jette, Douglas N. Greve, Lori B. Chibnik, Rebecca E. Amariglio, Gad A. Marshall, M. Brandon Westover   +13 more
wiley   +1 more source

Eye Tracking as Biomarker Compared to Neuropsychological Tests in Parkinson Syndromes: An Exploratory Pilot Study Before and After Deep Transcranial Magnetic Stimulation. [PDF]

Brain Sci
Cont C, Stute N, Galli A, Schulte C, Wojtecki L.   +4 more
europepmc   +1 more source

Neuropsychological Tests for Patients with Marchiafava-Bignami Disease: A Case Report. [PDF]

Psychiatry Investig, 2020
Youn H, Lee SI, Kim SG, Lee J, Jung HY.
europepmc   +1 more source

Areas of research priorities in epilepsy: A position paper of the European Reference Network for Rare and Complex Epilepsies, EpiCARE

Epilepsia Open, EarlyView.
Abstract Objective To define and articulate research priorities in epilepsy identified by the European Reference Network for Rare and Complex Epilepsies (ERN EpiCARE), addressing key unmet needs across the spectrum of rare and complex epilepsies. Methods This position paper was developed through a structured collaborative process involving patient ...
Sébile Tchaicha, Stéphane Auvin, Sándor Beniczky, Andreas Brunklaus, Lieven Lagae, Emilio Perucca, Rainer Surges, Sophie Adler, Christoph Helmstaedter, Floor Jansen, Guido Rubboli, Philippe Ryvlin, Nicola Specchio, Eugen Trinka, Ingmar Blümcke, Valentina de Giorgis, Katarzyna Kotulska, Gaetan Lesca, Masa Malenica, Amy McTague, Rima Nabbout, Rikke Steensbjerre Møller, Sandra Silva Arrieta, Isabella Brambilla, Małgorzata Kosla, Kees Braun, J. Helen Cross, Alexis Arzimanoglou   +27 more
wiley   +1 more source

Predicting the Progression of Mild Cognitive Impairment to Alzheimer's Dementia Using Recurrent Neural Networks With a Series of Neuropsychological Tests. [PDF]

J Clin Neurol
Park C, Joo G, Roh M, Shin S, Yum S, Yeo NY, Park SW, Jang JW, Im H, Alzheimer's Disease Neuroimaging Initiative.   +9 more
europepmc   +1 more source